Gambro/NNP first-half/JJ profits/NNS jump/VBP 18/CD percent/NN Swedish/JJ pharmaceutical/JJ group/NN Gambro/NNP on/IN Friday/NNP reported/VBD an/DT 18/CD percent/NN rise/NN in/IN pre-tax/JJ profits/NNS in/IN the/DT first/JJ half/NN of/IN 1994/CD ,/, to/TO 582/CD million/CD kronor/NNS -LRB-/-LRB- 75/CD million/CD dollars/NNS -RRB-/-RRB- against/IN 495/CD million/CD kronor/NNS -LRB-/-LRB- 63/CD million/CD dollars/NNS -RRB-/-RRB- in/IN 1992/CD ./.

Operating/VBG income/NN improved/VBD by/IN 9/CD percent/NN to/TO 723/CD million/CD kronor/NNS -LRB-/-LRB- 92.6/CD million/CD dollars/NNS -RRB-/-RRB- from/IN 664/CD million/CD kronor/NNS -LRB-/-LRB- 85/CD million/CD dollars/NNS -RRB-/-RRB- in/IN the/DT same/JJ period/NN last/JJ year/NN ./.

Sales/NNS during/IN the/DT first/JJ six/CD months/NNS rose/VBD to/TO 4.88/CD billion/CD kronor/NNS -LRB-/-LRB- 625.6/CD million/CD dollars/NNS -RRB-/-RRB- ,/, compared/VBN to/TO 4.32/CD billion/CD kronor/NNS -LRB-/-LRB- 554/CD million/CD dollars/NNS -RRB-/-RRB- during/IN the/DT corresponding/JJ period/NN last/JJ year/NN ./.

